Breaking News

Metrics Appoints Pharma Development VP

January 29, 2013

Gold expands role, to implement new technology platforms

Dr. Thomas B. “Brad” Gold has been appointed vice president of pharmaceutical development at Metrics, Inc. The promotion expands Dr. Gold’s previous role as senior director of pharmaceutical development and new technology. He will manage formulation development, potent and cytotoxic products, fast-track development, analytical methods development and validation. Mr. Gold will also be responsible for implementing new technology platforms that include advanced drug delivery methods. 
 
“After demonstrating solid leadership here at Metrics for more than 10 years, Brad has more than earned the trust and respect of our entire team,” said Phil Hodges, Metrics’ president. “He has the scientific knowledge and operational management skills we need to continue growing our core pharmaceutical development capabilities.”

Related Compliance:

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies

  • Talking Trends with Aesica

    Talking Trends with Aesica

    Tim Wright, editor||February 26, 2016
    Managing director Ian Muir fills us in on the latest at the CDMO